Safety and Efficacy of Underwater Endoscopic Mucosal Resection for Type I Gastric Neuroendocrine Tumors Measuring 5-9 mm
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Study objectives: Primary objective: 1.To determine the histologic R0 resection rate of UEMR for type I gastric NETs measuring 5-9 mm. Secondary objectives: To evaluate: 1. En bloc resection rate 2. Immediate and delayed adverse events 3. Procedure time 4. Histologic quality of resection (deep and lateral margins) 5. Residual disease at resection scar on surveillance endoscopy oMetachronous gastric NETs during follow-up
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek co najmniej 18 lat
- •Możliwość przeprowadzenia zabiegu endoskopowego i znieczulenia
- •Pisemna zgoda na udział w badaniu
✗ Disqualifies
- •Guz widoczny w endoskopii o rozmiarze 5-9 mm
- •Cechy odpowiadające typowi I guza neuroendokrynnego żołądka
- •Brak cech wskazujących na głęboką inwazję nowotworu
- •Możliwość usunięcia zabiegu pętlą endoskopową
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 65 Years
- Last updated (source)
- July 27, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Asian Institute of Gastroenterology/AIG Hospitals
Hyderabad, India
Trial contact
Rajesh Mr Goud, M.Pharmacy
Shashavali Dr Maniyar, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/28/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.